Temitayo A Ogunleye, MD
Professor of Clinical Dermatology
Department: Dermatology
Contact information
3400 Civic Center Blvd
7th Floor PCAM South, Room 773
Philadelphia, PA 19104-4283
7th Floor PCAM South, Room 773
Philadelphia, PA 19104-4283
Education:
BS
University of Pittsburgh, 2003.
MD
University of Pennsylvania, 2008.
MHCI (Master's in Health Care Innovation)
University of Pennsylvania, 2021.
BS
University of Pittsburgh, 2003.
MD
University of Pennsylvania, 2008.
MHCI (Master's in Health Care Innovation)
University of Pennsylvania, 2021.
Post-Graduate Training
Intern in Medicine, Albert Einstein Medical Center, 2008-2009.
Resident in Dermatology, University of Michigan Hospital System, Ann Arbor, 2009-2012.
Postdoctoral Researcher , University of Pennsylvania School of Medicine, 2012-2013.
Fellowship, Clinician-Educator, Hospital of the University of Pennsylvania, 2012-2013.
Intern in Medicine, Albert Einstein Medical Center, 2008-2009.
Resident in Dermatology, University of Michigan Hospital System, Ann Arbor, 2009-2012.
Postdoctoral Researcher , University of Pennsylvania School of Medicine, 2012-2013.
Fellowship, Clinician-Educator, Hospital of the University of Pennsylvania, 2012-2013.
Certifications
American Board of Dermatology, 2013.
Permanent linkAmerican Board of Dermatology, 2013.
Selected Publications
Alomary SA, Baker NJ, Schell N, Ogunleye T, Taylor S, Milbar H: An Analysis of TSH Levels in Patients with Nonscarring Alopecia: A Single-Center Retrospective Comparative Study. The Journal of Clinical and Aesthetic Dermatology April 2026.Baker NJ, Alomary SA, Ogunleye T, Taylor S: Risk of Psychiatric Comorbidities in Non-Scarring Versus Scarring Alopecia: A Retrospective Cohort Study. J Cutan Med Surg Apr 2026 Notes: Online ahead of print.
Alomary SA, Baker NJ, Ogunleye T, Taylor SC: Postmarketing safety of bimekizumab for hidradenitis suppurativa: An early pharmacovigilance analysis using the United States Food and Drug Administration Adverse Event Reporting System. JAAD Int 25: 92-94, Feb 2026.
Encarnacion IN, Desir N, Schell N, Mehta A, Ogunleye T, Taylor S: Visit Complexity Differs Between Scarring and Nonscarring Alopecia: A Five-Year DataDerm Analysis. J Am Acad Dermatol S0190-9622(26), Feb 2026 Notes: online ahead of print.
Encarnacion IN, Desir N, Anusionwu ID, Hislop C, Feldman E, Ogunleye T, Taylor S: GLP-1 Receptor Agonists in Overweight and Obese Patients with Hidradenitis Suppurativa. J Drugs Dermatol 25(2): 178-80, Feb 2026.
Ogunleye TA: Patient Perspectives on Scalp Biopsies for CCCA. Journal of Drugs in Dermatology Buzz Series 2026 Notes: https://nextstepsinderm.com/jdd-corner/jdd-buzz-series/jdd-author-buzz-patient-perspectives-on-scalp-biopsies-for-ccca/
Desir N, Encarnacion I, Oyasiji O, Durango K, Obeng-Nyarko C, Ogunleye, Taylor S: Intralesional corticosteroid injection technique for scarring and nonscarring alopecia: A cross-sectional survey of hair experts in the United States. JAAD Aug 2025.
Anusionwu I, Durango KP, Barrera TM, Ogunleye T, Taylor SC, Mollanazar N: The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients with Atopic Dermatitis: A Retrospective Chart Review. J Drugs Dermatol 24: 8749, Aug 2025.
Desir N, Encarnacion I, Ogunleye T, Taylor S: Scalp pain or tenderness may offer diagnostic clues regarding cicatricial alopecia subtype. JAAD Aug 2025.
Starks S: CCCA. Allure Jun 2025.